entertainment -WSS

entertainment

author：leisure time 2025-10-02 23:45:09 - browse：4

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Physicians and social media: If you see something, say something?

WSS

Medicare Advantage insurers pressure Biden for bigger payments

Chinese researcher claims birth of first gene

Colonoscopy prep: Liquid

Physicians and social media: If you see something, say something?

Virtual Event: March of the Biosimilars

App could help diagnose ear infections more accurately — and at home

Wikipedia

entertainment

hotspot

Walensky prepares to leave CDC — and Congress — behind

SCOTUS questions limit to govt efforts to fight misinformation

BioMarin wins approval for gene therapy to treat hemophilia A

Steward Health Care expansion into Malta flopped

Anesthesiologist group: stop taking Ozempic before surgery

Erich Jarvis studies song birds to learn about human stuttering

How to save PrEP access — and even expand it

Future doctors should be trained to promote social change

Medical records are filled with copy

Colonoscopy prep: Liquid

hotspot

Health AI adoption puts security, privacy startups on investors' radar

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Steward Health Care expansion into Malta flopped

What Kate Middleton's cancer revelation might teach the world

Methadone treatment changes are coming. Do they go far enough?

Creating egg and sperm cells from stem cells raises ethical issues

hotspot

Wikipedia

entertainment

leisure time